Guardant Health, Inc.
GH
$48.30
$0.891.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -436.37M | -512.41M | -490.76M | -460.90M | -479.45M |
| Total Depreciation and Amortization | 42.39M | 42.80M | 43.24M | 43.25M | 42.88M |
| Total Amortization of Deferred Charges | 2.58M | 2.58M | 2.58M | 2.58M | 2.58M |
| Total Other Non-Cash Items | 212.41M | 206.82M | 154.19M | 90.76M | 55.18M |
| Change in Net Operating Assets | -60.86M | 6.14M | 9.95M | 43.50M | 53.84M |
| Cash from Operations | -239.86M | -254.07M | -280.81M | -280.82M | -324.98M |
| Capital Expenditure | -35.09M | -20.29M | -18.46M | -19.90M | -20.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -226.22M | 411.90M | 965.60M | 730.99M | 860.74M |
| Cash from Investing | -261.31M | 391.62M | 947.14M | 711.09M | 840.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.84M | 104.00M | 104.05M | 503.73M | 503.68M |
| Repurchase of Common Stock | -15.68M | -10.74M | -10.87M | -11.75M | -11.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -153.00K | -747.00K | 6.02M | -14.83M | -15.10M |
| Cash from Financing | -996.00K | 92.51M | 99.20M | 477.16M | 477.38M |
| Foreign Exchange rate Adjustments | -1.77M | 955.00K | -1.47M | -1.89M | -911.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -503.93M | 231.01M | 764.07M | 905.54M | 991.74M |